Elsevier Inc.

SHERPA: Unknown

People

  1. Zhang
    Zhang
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Devlin
    Devlin
  5. Iasonos
    Iasonos
  6. Seshan
    Seshan
  7. Chi
    Chi
  8. Zhou
    Zhou
  9. Abu-Rustum
    Abu-Rustum
  10. Shah
    Shah

Groups

  1. Epidemiology and Biostatistics (1206)
  2. Biostatistics Service (930)
  3. Department of Medicine (680)
  4. Survivorship Research (592)
  5. Surgery (482)
  6. Solid Tumor Oncology Division (388)
  7. Population Sciences Research Program (385)
  8. Hematologic Malignancies, Division of (303)
  9. Radiation Oncology, Department of (297)
  10. GSK Faculty (279)
Search Within
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (668)
  2. Meeting Abstract (507)
  3. Review (9)
  4. Research Letter (6)
  5. Book Section (5)
  6. Correspondence (5)
  7. Editorial (4)
  8. Conference Paper (2)
Groups
  1. Epidemiology and Biostatistics (1206)
  2. Biostatistics Service (930)
  3. Department of Medicine (680)
  4. Survivorship Research (592)
  5. Surgery (482)
  6. Solid Tumor Oncology Division (388)

More Groups

People
  1. Zhigang Zhang (213)
  2. Sean Devlin (175)
  3. Sergio Giralt (174)
  4. Miguel-Angel Perales (125)
  5. Alexia Iasonos (113)
  6. Venkatraman Seshan (94)

More People

Years
  1. 2025 (20)
  2. 2024 (82)
  3. 2023 (98)
  4. 2022 (71)
  5. 2021 (67)
  6. 2020 (78)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (258)
  2. Gynecologic Oncology (183)
  3. Biology of Blood and Marrow Transplantation (175)
  4. Journal of Thoracic Oncology (94)
  5. Gastroenterology (49)
  6. Urologic Oncology: Seminars and Original Investigations (45)

More Publications

Results (1206)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K.; Papadimitriou, M.; Blaney, P.; McPherson, A.; Chu, T.; Diamond, B.; Ziccheddu, B.; Shekarkhand, T.; Poos, A.; Brown, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of teclistamab among MajesTEC-1 eligible and ineligible population in the real-world setting for the treatment of relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Rajeeve, S.; Hashmi, H.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of granulocyte colony-stimulating factor exposure on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma
    Meeting Abstract

    Wang, A.; Shekarkhand, T.; Derkach, A.; Nemirovsky, D.; Tan, C.; Hamadeh, I.; Firestone, R.; Jurgens, E.; Miller, K.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Single cell whole genome measurement of genomic heterogeneity and clonal evolution in multiple myeloma
    Meeting Abstract

    McPherson, A.; Maclachlan, K.; Myers, M.; Satas, G.; GarceĢs, J. J.; Lee, H.; Bahlis, N. J.; Usmani, S.; Shah, S.; Maura, F.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for multiple myeloma patients with three-year sustained mrd negative remissions
    Meeting Abstract

    Korde, N.; Hassoun, H.; Landau, H.; Hamid, S.; Derkach, A.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations
    Journal Article

    Moufarrij, S.; Dagher, C.; Filippova, O. T.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Mueller, J. J.; Leitao, M. M.; Sandhu, J.; Bochner, B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Ultra-hypofractionated whole breast radiation therapy using a novel boost regimen for early-stage breast cancer
    Meeting Abstract

    Chakraborty, M. A.; Khan, A. J.; Tadros, A. B.; White, C.; Kim, M.; Zhang, Z.; Braunstein, L. Z.; Xu, A. J.; LaPlant, Q.; Roth O'Brien, D. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save